Medicis was founded in 1988[1] by Jonah Shacknai[4] and John Holaday.[5]
In September 2012 Canadian based Valeant Pharmaceuticals and Medicis' management agreed that Valeant would acquire Medicis for 2.6 billion dollars, or $44/share, 39 percent more than the stock’s Aug. 31 closing price. The deal was subject to shareholder and regulatory approvals.[11]
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.